Introduced in the late 1950s, polyenes represent the oldest family of antifungal drugs. The
discovery of amphotericin B and its therapeutic uses is considered one of the most important …

Leishmaniasis is a parasitic disease that presents four main clinical syndromes: cutaneous
leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), visceral leishmaniasis/kala azar …

It is important to realize that leishmaniasis guidelines cannot always account for individual
variation among patients. They are not intended to supplant physician judgment with respect …

Introduction: Leishmaniasis broadly manifests as visceral leishmaniasis (VL), cutaneous
leishmaniasis (CL) and mucocutaneous leishmaniasis. The treatment of leishmaniasis is …

Introduction: Leishmaniasis broadly manifests as visceral leishmaniasis (VL), cutaneous
leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL). The treatment of VL is …

Cutaneous leishmaniasis (CL) is a complex skin infection that has imposed a heavy burden
on many developing countries and is caused by more than 20 Leishmania species. This …

Introduction: Leishmaniasis is a parasitic disease transmitted by phlebotomine sandflies.
Between 700,000 and 1.2 million cases of cutaneous leishmaniasis and between 200,000 …

Estimated worldwide incidence of tegumentary leishmaniasis (cutaneous leishmaniasis [CL]
and mucocutaneous leishmaniasis [MCL]) is over 1.5 million cases per year in 82 countries …

Leishmaniasis is a vector-borne infection caused by kinetoplastid protozoans in the genera
Leishmania and Endotrypanum. The disease occurs worldwide in the tropics and subtropics …

Leishmaniasis is one of eight neglected tropical diseases currently endemic in 102
countries/areas around the world. In recent years, cutaneous leishmaniasis (CL) has been …